Literature DB >> 14752729

Intrafractional tumor motion: lung and liver.

Hiroki Shirato1, Yvette Seppenwoolde, Kei Kitamura, Rikiya Onimura, Shinichi Shimizu.   

Abstract

Three-dimensional (3D) dose distribution has been improved by 3D conformation and intensity modulation in external radiotherapy. Interfractional uncertainty has been reduced by image-guided setup techniques. Reduction of ambiguity because of intrafractional target motion is the next step forward. Respiratory organ motion is known to be the largest intrafractional organ motion. Radiotherapy techniques controlling, gating, or tracking respiratory motion are under investigation to use smaller safety margins and higher doses for moving tumors. However, data on intrafractional tumor motion are sparse. We developed a fluoroscopic real-time tracking system and implantation techniques of fiducial markers for moving organs and have been accumulating knowledge about internal tumor motion. We also found the importance of 4-dimensional treatment planning to account for tumor motion in precision radiotherapy. This article reviews the current basic knowledge on respiratory physiology and summarizes the accumulating knowledge on internal motion of lung and liver tumors.

Entities:  

Mesh:

Year:  2004        PMID: 14752729     DOI: 10.1053/j.semradonc.2003.10.008

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  52 in total

1.  In vivo reproducibility of robotic probe placement for a novel ultrasound-guided radiation therapy system.

Authors:  Muyinatu A Lediju Bell; H Tutkun Sen; Iulian Iordachita; Peter Kazanzides; John Wong
Journal:  J Med Imaging (Bellingham)       Date:  2014-07-23

Review 2.  Radiation-associated liver injury.

Authors:  Charlie C Pan; Brian D Kavanagh; Laura A Dawson; X Allen Li; Shiva K Das; Moyed Miften; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 3.  [Visualization of pulmonary nodules with magnetic resonance imaging (MRI)].

Authors:  C Plathow; H-P Meinzer; H-U Kauczor
Journal:  Radiologe       Date:  2006-04       Impact factor: 0.635

Review 4.  Organ motion in image-guided radiotherapy: lessons from real-time tumor-tracking radiotherapy.

Authors:  Hiroki Shirato; Shinichi Shimizu; Kei Kitamura; Rikiya Onimaru
Journal:  Int J Clin Oncol       Date:  2007-02-25       Impact factor: 3.402

5.  Assessment of patient selection criteria for quantitative imaging with respiratory-gated positron emission tomography.

Authors:  Stephen R Bowen; Larry A Pierce; Adam M Alessio; Chi Liu; Scott D Wollenweber; Charles W Stearns; Paul E Kinahan
Journal:  J Med Imaging (Bellingham)       Date:  2014-09-24

6.  Combined kV and MV imaging for real-time tracking of implanted fiducial markers.

Authors:  R D Wiersma; Weihua Mao; L Xing
Journal:  Med Phys       Date:  2008-04       Impact factor: 4.071

7.  Evaluation of reproducibility of tumor repositioning during multiple breathing cycles for liver stereotactic body radiotherapy treatment.

Authors:  Ludovic Bedos; Olivier Riou; Norbert Aillères; Antoine Braccini; Jessica Molinier; Carmen Llacer Moscardo; David Azria; Pascal Fenoglietto
Journal:  Rep Pract Oncol Radiother       Date:  2016-11-12

8.  Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: A review from NRG oncology.

Authors:  Edward D Brandner; Indrin J Chetty; Tawfik G Giaddui; Ying Xiao; M Saiful Huq
Journal:  Med Phys       Date:  2017-04-20       Impact factor: 4.071

9.  Lung tumor tracking in fluoroscopic video based on optical flow.

Authors:  Qianyi Xu; Russell J Hamilton; Robert A Schowengerdt; Brian Alexander; Steve B Jiang
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

10.  Four-dimensional deformable image registration using trajectory modeling.

Authors:  Edward Castillo; Richard Castillo; Josue Martinez; Maithili Shenoy; Thomas Guerrero
Journal:  Phys Med Biol       Date:  2010-01-07       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.